Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Apr 04, 2024

SELL
$36.12 - $47.5 $1,408 - $1,852
-39 Closed
0 $0
Q1 2023

Apr 04, 2024

BUY
$35.53 - $43.38 $1,385 - $1,691
39 New
39 $1.59 Million
Q4 2022

Apr 04, 2024

SELL
$38.19 - $57.45 $114 - $172
-3 Closed
0 $0
Q2 2022

Apr 04, 2024

BUY
$51.49 - $81.64 $154 - $244
3 New
3 $175,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Financial Synergies Wealth Advisors, Inc. Portfolio

Follow Financial Synergies Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.